Terms: = Lung cancer AND CLTC, CLTCL2, 1213, ENSG00000141367, Q00610 AND Treatment
33 results:
1. Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study.
Bamias A; Davis ID; Galsky MD; Arranz JÁ; Kikuchi E; Grande E; Del Muro XG; Park SH; De Giorgi U; Alekseev B; Mencinger M; Izumi K; Schutz FA; Puente J; Li JR; Panni S; Gumus M; Özgüroğlu M; Mariathasan S; Poloz Y; Bene-Tchaleu F; Lee C; Bernhard S; De Santis M
Lancet Oncol; 2024 Jan; 25(1):46-61. PubMed ID: 38101431
[TBL] [Abstract] [Full Text] [Related]
2. Acquired resistance to crizotinib in novel CDK14-ALK and cltc-ALK fusions of ALK-positive large B-cell lymphoma identified by next-generation sequencing.
Xia Y; Zhang L; He W; Pan H; Fang J; Cui G
Cancer Biol Ther; 2023 Dec; 24(1):2271212. PubMed ID: 37906510
[TBL] [Abstract] [Full Text] [Related]
3. Long-term outcome after surgical resection of non-high-risk gastrointestinal stromal tumours without adjuvant therapy.
Berndsen M; Renberg S; Hølmebakk T; Hancke E; Puls F; Karlsson F; Stoldt S; Bjerkehagen B; Haglund de Flon F; Muth A; Papakonstantinou A; Boye K; Lindskog S
Br J Surg; 2023 Nov; 110(12):1857-1862. PubMed ID: 37758514
[TBL] [Abstract] [Full Text] [Related]
4. Thromboembolic and bleeding complications during interruptions and after discontinuation of anticoagulant treatment in patients with atrial fibrillation and active cancer: A daily practice evaluation.
Chu G; Seelig J; Cannegieter SC; Gelderblom H; Hovens MMC; Huisman MV; van der Hulle T; Trines SA; Vlot AJ; Versteeg HH; Hemels M; Klok FA
Thromb Res; 2023 Oct; 230():98-104. PubMed ID: 37703801
[TBL] [Abstract] [Full Text] [Related]
5. A multicenter, single-arm, open study of neoadjuvant or conversion atezolizumab in combination with chemotherapy in resectable small cell lung cancer (Cohort Study).
Duan H; Shi L; Shao C; Wang Y; Wang Z; Ni Y; Zhao J; Sun J; Tong L; Lei J; Jiang T; Liu Z; Yan X
Int J Surg; 2023 Sep; 109(9):2641-2649. PubMed ID: 37428211
[TBL] [Abstract] [Full Text] [Related]
6. [Mucinous tubular and spindle cell carcinoma of kidney: Clinicopathology and prognosis].
Shen Q; Liu YX; He Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):276-282. PubMed ID: 37042138
[TBL] [Abstract] [Full Text] [Related]
7. Association Between Surgical Quality Metric Adherence and Overall Survival Among US Veterans With Early-Stage Non-Small Cell lung cancer.
Heiden BT; Eaton DB; Chang SH; Yan Y; Baumann AA; Schoen MW; Tohmasi S; Rossetti NE; Patel MR; Kreisel D; Nava RG; Meyers BF; Kozower BD; Puri V
JAMA Surg; 2023 Mar; 158(3):293-301. PubMed ID: 36652269
[TBL] [Abstract] [Full Text] [Related]
8. Impact of PD1 and PDL1 immunotherapy on non-small cell lung cancer outcomes: a systematic review.
Kanabar SS; Tiwari A; Soran V; Balendran P; Price M; Turner AM
Thorax; 2022 Dec; 77(12):1163-1174. PubMed ID: 35688624
[TBL] [Abstract] [Full Text] [Related]
9. Molecular mechanism of the uptake and toxicity of EGF-LipoAgNPs in EGFR-overexpressing cancer cells.
Skóra B; Szychowski KA
Biomed Pharmacother; 2022 Jun; 150():113085. PubMed ID: 35658239
[TBL] [Abstract] [Full Text] [Related]
10. Investigating the genomic alteration improved the clinical outcome of aged patients with lung carcinoma.
Chen S; Fu A; Lu Y; Lu W; Chen Y; Hong S; Zhou S; Xiang T; Zhang Z; Cai Y
BMC Genomics; 2022 Jan; 23(1):55. PubMed ID: 35031014
[TBL] [Abstract] [Full Text] [Related]
11. [Clinicopathological features and molecular genetic changes of lung salivary gland-type clear cell carcinoma].
Xue QQ; Huang Y; Zuo SY; Zheng Q; Ji G; Zhou XY; Wu CY; Li Y
Zhonghua Bing Li Xue Za Zhi; 2021 Jul; 50(7):728-733. PubMed ID: 34405605
[No Abstract] [Full Text] [Related]
12. Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions.
Mondaca S; Lebow ES; Namakydoust A; Razavi P; Reis-Filho JS; Shen R; Offin M; Tu HY; Murciano-Goroff Y; Xu C; Makhnin A; Martinez A; Pavlakis N; Clarke S; Itchins M; Lee A; Rimner A; Gomez D; Rocco G; Chaft JE; Riely GJ; Rudin CM; Jones DR; Li M; Shaffer T; Hosseini SA; Bertucci C; Lim LP; Drilon A; Berger MF; Benayed R; Arcila ME; Isbell JM; Li BT
Lung Cancer; 2021 Sep; 159():66-73. PubMed ID: 34311346
[TBL] [Abstract] [Full Text] [Related]
13. SAKK 19/17: safety analysis of first-line durvalumab in patients with PD-L1 positive, advanced nonsmall cell lung cancer and a performance status of 2.
Mark M; Froesch P; Eboulet EI; Addeo A; Pless M; Rothschild SI; Janthur WD; Burmeister H; Friedlaender A; Schneider M; Metaxas Y; Joerger M; Wannesson L; Schwitter M; Baudoux N; Weindler S; Biaggi-Rudolf C; Früh M;
Cancer Immunol Immunother; 2021 May; 70(5):1255-1262. PubMed ID: 33130956
[TBL] [Abstract] [Full Text] [Related]
14. Impact of Next Generation Sequencing on Clinical Practice in Oncology in France: Better Genetic Profiles for Patients Improve Access to Experimental treatments.
Coquerelle S; Darlington M; Michel M; Durand M; Borget I; Baffert S; Marino P; Perrier L; Durand-Zaleski I;
Value Health; 2020 Jul; 23(7):898-906. PubMed ID: 32762992
[TBL] [Abstract] [Full Text] [Related]
15. DC-HIL/Gpnmb Is a Negative Regulator of Tumor Response to Immune Checkpoint Inhibitors.
Chung JS; Ramani V; Kobayashi M; Fattah F; Popat V; Zhang S; Cruz PD; Gerber DE; Ariizumi K
Clin Cancer Res; 2020 Mar; 26(6):1449-1459. PubMed ID: 31822499
[TBL] [Abstract] [Full Text] [Related]
16. Breathing-motion-compensated robotic guided stereotactic body radiation therapy : Patterns of failure analysis.
Stera S; Balermpas P; Chan MKH; Huttenlocher S; Wurster S; Keller C; Imhoff D; Rades D; Dunst J; Rödel C; Hildebrandt G; Blanck O
Strahlenther Onkol; 2018 Feb; 194(2):143-155. PubMed ID: 28875297
[TBL] [Abstract] [Full Text] [Related]
17. Hospitalization costs of lung cancer diagnosis in Turkey: Is there a difference between histological types and stages?
Türk M; Yıldırım F; Yurdakul AS; Öztürk C
Tuberk Toraks; 2016 Dec; 64(4):263-268. PubMed ID: 28393715
[TBL] [Abstract] [Full Text] [Related]
18. WILLINGNESS TO PAY FOR lung cancer treatment: PATIENT VERSUS GENERAL PUBLIC VALUES.
Thongprasert S; Crawford B; Sakulbumrungsil R; Chaiyakunapruk N; Petcharapiruch S; Leartsakulpanitch J; Permsuwan U
Int J Technol Assess Health Care; 2015 Jan; 31(4):264-70. PubMed ID: 26353902
[TBL] [Abstract] [Full Text] [Related]
19. Clinicopathological spectrum of a series of Merkel cell carcinomas diagnosed at a tertiary cancer referral center in India, with current concepts.
Rekhi B; Kane SV; Jambhekar NA
Ann Diagn Pathol; 2015 Oct; 19(5):341-6. PubMed ID: 26254510
[TBL] [Abstract] [Full Text] [Related]
20. EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition.
Rotella V; Fornaro L; Vasile E; Tibaldi C; Boldrini L; Chella A; D'Incecco A; Cirigliano G; Chioni A; Lupi C; Sensi E; Ginocchi L; Giovannelli S; Pennucci MC; Fontanini G; Baldini E
J Exp Clin Cancer Res; 2014 Oct; 33(1):77. PubMed ID: 25300933
[TBL] [Abstract] [Full Text] [Related]
[Next]
